4-hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidene cyanoacetamide,
AG 825,
AG825,
tyrphostin AG825,
AG 825,
Tyrphostin AG 825,
149092-50-2,
AG-825,
CHEMBL118109,
CHEBI:75405,
Tyrphostin C15,
4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide,
SR-01000597586,
MFCD01074971,
Tocris-1555,
BiomolKI_000008,
BiomolKI2_000018,
AC1O19WX,
BMK1-B8,
BSPBio_001182,
BCBcMAP01_000031,
5-[(Benzothiazol-2-yl)thiomethyl]-4-hydroxy-3-methoxybenzylidenecyanoacetamide,
HMS1362L03,
HMS1792L03,
HMS1990L03,
HMS3403L03,
HMS3678M07,
ZINC2572484,
BDBM50036691,
HSCI1_000169,
Tyrphostin AG 825, >=92.5%,
AKOS024456662,
CCG-100612,
IDI1_002186,
NCGC00025214-01,
NCGC00025214-02,
NCGC00025214-03,
NCGC00025214-04,
B6788,
EC-000.2084,
092A502,
J-008550,
SR-01000597586-1,
SR-01000597586-2,
BRD-K87919739-001-04-2,
(E)-3-(3-((benzo[d]thiazol-2-ylthio)methyl)-4-hydroxy-5-methoxyphenyl)-2-cyanoacrylamide,
(E)-3-[3-(Benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,
(E)-3-[3-[2-Benzothiazolythio)methyl]-4-hydroxy-5-methoxyphenyl]-2-cyano-2-propenamide,
3-[3-(Benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,
(2E)-3-{3-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-hydroxy-5-methoxyphenyl}-2-cyanoprop-2-enamide,
(E)-3-[3-(1,3-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxyphenyl]-2-cyanoprop-2-enamide,
2-Propenamide,
tyrphostin AG825,
ag825,
CID6091659,
C098214,
3-[3-[(2-Benzothiazolylthio)methyl]-4-hydroxy-5-methoxyphenyl]-2-cyano-,
4-hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidene cyanoacetamide,